Genentech’s TECENTRIQ Upcoming Webinars
- September 15, 2016
- e-Learning, News
On behalf of Genentech, you are invited to attend one of three webcasts across two days that span lunch times across 3 time zones:
Introducing TECENTRIQ: The First and Only FDA-Approved Anti-PDL1 Immunotherapy for Previously Treated Locally Advanced Metastatic Urothelial Carcinoma
September 28, 2016 Fairooz Kabbinavar, MD – UCLA, Los Angeles, CA
3:00pm ET, 2:00pm CT,1:00pm MT, 12:00pm PT
September 28, 2016 Arash Rezazdeh, MD – Norton Cancer Institute, Louisville, KY
12:00pm ET, 11:00am CT, 10:00am MT, 9:00am PT
September 29, 2016 John Powderly, MD – Carolina BioOncology Institute, Huntersville, NC
1:00pm ET, 12:00pm CT, 11:00am MT, 10:00am PT
